drugset

drugset / Trial / NCT00630851

A Study of the Efficacy and Safety of Aricept in Patients With Severe Alzheimer's Disease Who Are Living in Skilled Nursing Homes

NCT00630851 ↗

Phase 3 Completed 249 enrolled Pfizer

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to evaluate the efficacy and safety of Aricept in nursing home patients with severe Alzheimer's disease.

Timeline

Start: 2002-10
Primary completion: —
Completion: 2004-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Donepezil	Small molecule	10 mg	Oral

Indications